ALNYLAM PHARMACEUTICALS, INC. Quotes Alnylam Pharmaceuticals, Inc. BOERSE MUENCHEN
Equities
DUL
US02043Q1076
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230.7 EUR | -2.29% |
|
+0.43% | +33.39% |
| Jul. 15 | Alnylam Pharmaceuticals Insider Sold Shares Worth $1,851,273, According to a Recent SEC Filing | MT |
| Jul. 03 | Jerome Powell did it again |  |
Quotes 5-day view
Real-time BOERSE MUENCHEN| 2024-07-11 | 2024-07-12 | 2024-07-15 | 2024-07-16 | |
|---|---|---|---|---|
| Last | 241.5 € | 240.7 € | 236.1 € | 230.7 € |
| Volume | 30 | 0 | 28 | 72 |
| Change | +2.29% | -0.33% | -1.91% | -2.29% |
| Opening | 236.20 | 241.00 | 240.70 | 236.10 |
| High | 241.50 | 241.00 | 241.50 | 239.20 |
| Low | 236.20 | 240.30 | 234.50 | 230.10 |
Performance
| 1 week | -2.08% | ||
| Current month | +1.41% | ||
| 1 month | +54.06% | ||
| 3 months | +66.39% | ||
| 6 months | +34.13% | ||
| Current year | +30.34% | ||
| 1 year | +30.93% | ||
| 3 years | +53.85% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
32 404 663 688
Capitalization (USD)
32 404 663 688
Net sales (USD)
1 828 292 000
Free-Float
99.58 %
Free-Float capitalization (EUR)
35 163 547 547
Free-Float capitalization (USD)
32 268 145 878
Average Daily Capital Traded
0%
Highs and lows
1 week
230.10
241.50
1 month
141.95241.50
3 years
113.70241.50
Indicators
Moving average 5 days
238.00
Moving average 20 days
209.48
Moving average 50 days
167.73
Moving average 100 days
154.61
Price spread / (MMA5)
+3.16%
Price spread / (MMA20)
-9.20%
Price spread / (MMA50)
-27.29%
Price spread / (MMA100)
-32.98%
STIM
RSI 9 days
88.35
RSI 14 days
87.32
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
a8ad347214f35d7f2f961b47daae89.PfEGhLT_XAMCdI-debE4gsP5aR4vi6f77IYdD_XZ0rc.R8lO9cCmJUgxHcqrHfZhw_qMAlF_z5e1qtJLaceag8R-w1n2mbcRUlcz2g
| Date | Price | Volume | Daily volume |
|---|
Monthly variations
Annual change
| 2024 | +30.34% | ||
| 2023 | -20.49% | ||
| 2022 | +48.60% | ||
| 2021 | +40.31% | ||
| 2020 | +1.33% |
- Stock Market
- Equities
- ALNY Stock
- DUL Stock
- Quotes Alnylam Pharmaceuticals, Inc.
